510(k) K150825
K150825 is an FDA 510(k) premarket notification submitted by Collagen Matrix, Inc. for the device "Collagen Dural Regeneration Matrix". The FDA issued a decision of Substantially Equivalent on November 20, 2015. The device falls under product code GXQ (Dura Substitute), a Class II device regulated under 21 CFR 882.5910. Collagen Matrix, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 20, 2015
- Date Received
- March 27, 2015
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Dura Substitute
- Device Class
- Class II
- Regulation Number
- 882.5910
- Review Panel
- NE
- Submission Type